Gregory D Leonard Selected Research

Fluorouracil (Carac)

3/2006	Continued survival of more than ten years, without resection of metastatic disease, in patients with metastatic colorectal cancer treated with biomodulated fluorouracil: report of two cases.
6/2005	A phase I pharmacologic and pharmacogenetic trial of sequential 24-hour infusion of irinotecan followed by leucovorin and a 48-hour infusion of fluorouracil in adult patients with solid tumors.
10/2002	Epirubicin, Cisplatin, and protracted venous-infusion Fluorouracil in advanced esophagogastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory D Leonard Research Topics

Disease

9	Neoplasms (Cancer) 03/2006 - 10/2002
6	Colorectal Neoplasms (Colorectal Cancer) 03/2006 - 08/2004
2	Neoplasm Metastasis (Metastasis) 09/2005 - 03/2005
2	Breast Neoplasms (Breast Cancer) 06/2004 - 01/2003
1	Adenocarcinoma 05/2008
1	Carcinoma (Carcinomatosis) 05/2008
1	Hand-Foot Syndrome 01/2006
1	Alopecia (Baldness) 01/2006
1	Mucositis 01/2006
1	Hypersensitivity (Allergy) 01/2006
1	Erythema Multiforme 01/2006
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2006
1	Diarrhea 06/2005
1	Nausea 06/2005
1	Neutropenia 06/2005
1	Margins of Excision 02/2005
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 02/2005
1	Job Syndrome (Hyper-IgE Syndrome) 12/2004
1	Lymphoma (Lymphomas) 12/2004
1	Abscess 12/2004
1	Pneumonia (Pneumonitis) 12/2004
1	Reinfection 12/2004
1	Polyneuropathies (Polyneuropathy) 08/2004
1	Esophageal Squamous Cell Carcinoma 08/2004
1	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2004
1	Ovarian Neoplasms (Ovarian Cancer) 03/2004
1	Leukemia 01/2003
1	Kidney Neoplasms (Kidney Cancer) 01/2003
1	Prostatic Neoplasms (Prostate Cancer) 01/2003
1	Disease Progression 01/2003

Drug/Important Bio-Agent (IBA)

3	Fluorouracil (Carac)FDA LinkGeneric 03/2006 - 10/2002
2	Capecitabine (Xeloda)FDA Link 09/2005 - 08/2004
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2005 - 08/2004
1	SynaptophysinIBA 05/2008
1	MucinsIBA 05/2008
1	ChromograninsIBA 05/2008
1	MouthwashesIBA 01/2006
1	Pharmaceutical PreparationsIBA 09/2005
1	Irinotecan (Camptosar)FDA LinkGeneric 06/2005
1	AntiemeticsIBA 06/2005
1	Leucovorin (Folinic Acid)FDA Link 06/2005
1	Immunoglobulin E (IgE)IBA 12/2004
1	Estrogen ReceptorsIBA 06/2004
1	Tamoxifen FDA LinkGeneric 06/2004
1	AntigensIBA 03/2004
1	CA-125 Antigen (CA 125 Antigen)IBA 03/2004
1	AndrogensIBA 01/2003
1	Thalidomide (Thalomid)FDA Link 01/2003
1	VA 061 (VA061)IBA 01/2003
1	Docetaxel (Taxotere)FDA Link 01/2003
1	Epirubicin (Ellence)FDA LinkGeneric 10/2002
1	Cisplatin (Platino)FDA LinkGeneric 10/2002

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 03/2006 - 01/2003
7	Therapeutics 01/2006 - 01/2003
3	Combination Drug Therapy (Combination Chemotherapy) 03/2006 - 08/2004
1	Premedication 01/2006
1	Neoadjuvant Therapy 03/2005
1	Biological Therapy 02/2005
1	Mastectomy (Mammectomy) 06/2004